Home > National Drug Code (NDC) > Terazosin Hydrochloride

Terazosin Hydrochloride - 0781-2052-05 - (Terazosin Hydrochloride)

Alphabetical Index


Drug Information of Terazosin Hydrochloride

Product NDC: 0781-2052
Proprietary Name: Terazosin Hydrochloride
Non Proprietary Name: Terazosin Hydrochloride
Active Ingredient(s): 2    mg/1 & nbsp;   Terazosin Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Terazosin Hydrochloride

Product NDC: 0781-2052
Labeler Name: Sandoz Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA074823
Marketing Category: ANDA
Start Marketing Date: 19980330

Package Information of Terazosin Hydrochloride

Package NDC: 0781-2052-05
Package Description: 500 CAPSULE in 1 BOTTLE (0781-2052-05)

NDC Information of Terazosin Hydrochloride

NDC Code 0781-2052-05
Proprietary Name Terazosin Hydrochloride
Package Description 500 CAPSULE in 1 BOTTLE (0781-2052-05)
Product NDC 0781-2052
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Terazosin Hydrochloride
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 19980330
Marketing Category Name ANDA
Labeler Name Sandoz Inc
Substance Name TERAZOSIN HYDROCHLORIDE
Strength Number 2
Strength Unit mg/1
Pharmaceutical Classes Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

Complete Information of Terazosin Hydrochloride


General Information